Envestnet Portfolio Solutions’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
9,680
+788
+9% +$145K 0.01% 517
2026
Q1
$1.68M Sell
8,892
-1,117
-11% -$235K 0.01% 497
2025
Q4
$1.99M Sell
10,009
-1,469
-13% -$297K 0.01% 548
2025
Q3
$2.33M Sell
11,478
-4,316
-27% -$766K 0.01% 498
2025
Q2
$2.78M Buy
15,794
+5,839
+59% +$879K 0.01% 479
2025
Q1
$1.34M Sell
9,955
-2,692
-21% -$355K 0.01% 713
2024
Q4
$1.6M Buy
12,647
+186
+1% +$27.7K 0.01% 749
2024
Q3
$2.07M Sell
12,461
-326
-3% -$49.3K 0.01% 650
2024
Q2
$1.7M Buy
12,787
+7,078
+124% +$852K 0.01% 683
2024
Q1
$600K Buy
5,709
+880
+18% +$79.1K ﹤0.01% 1036
2023
Q4
$365K Buy
4,829
+221
+5% +$14K ﹤0.01% 1193
2023
Q3
$304K Buy
+4,608
New +$345K ﹤0.01% 1223

Other funds holding THC

Envestnet Portfolio Solutions's THC Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Tenet Healthcare (THC) stake by 8.9% in Q2 2026, buying an estimated $145K and bringing the position to 9,680 shares worth $1.81M. The position accounts for 0.01% of the portfolio, ranked #517.

Envestnet Portfolio Solutions first reported a position in THC in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.78M in Q2 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Envestnet Portfolio Solutions held 9,680 shares of Tenet Healthcare worth $1.81M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 788 Tenet Healthcare shares in Q2 2026, an estimated $145K.
  • Tenet Healthcare made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #517 holding.
  • Envestnet Portfolio Solutions first reported a position in Tenet Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Tenet Healthcare position peaked at $2.78M in Q2 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.